Radial head fractures account for approximately one-third of all adult elbow fractures.[@bib17]^,^[@bib36] Under the Mason classification system, radial head fractures are classified as either with displacement or without displacement.[@bib19]^,^[@bib36] Radial head arthroplasty (RHA) is a surgical option for displaced radial head fractures.[@bib1] Current RHA can be classified as unfixed or fixed depending on how rigidly secured the implant is within the radial neck. Unfixed, or loose, implants have smooth shafts and allow for motion to occur within the medullary canal.[@bib1] Fixed, or press-fit, implants rigidly secure the implant within the canal of the radial neck.[@bib1] The type of implant may influence elbow stability and postoperative outcomes.[@bib4]

Agyeman et al[@bib1] conducted a systematic review to study the differences between the 2 fixation methods of RHA: fixed and unfixed. They concluded that implant fixation type does not appear to affect functional outcomes; however, their results suggested that rigidly fixed implants may increase the risks of revision and overall complications.

Numerous fixed-stem implants exist, with devices being manufactured by various companies. Currently, all fixed-stem RHA implants have been considered equal; therefore, we conducted a systematic review to evaluate the different types of fixed-stem implants in terms of their safety and efficacy. We hypothesized that differences exist between these implants and they should not be considered the same.

Methods {#sec1}
=======

Search strategy {#sec1.1}
---------------

We conducted an updated systematic review using the same methodology reported by Agyeman et al.[@bib1] Electronic literature searches were conducted in the MEDLINE and Embase databases using the following search algorithm: radial head AND (arthroplasty OR prosthesis OR replacement). The search was conducted from January 22, 2017---as this was the date reported by Agyeman et al---to November 20, 2018.

Eligibility criteria {#sec1.2}
--------------------

We included any clinical study published in English evaluating the use of an RHA device for any indication; however, we only included studies that evaluated a fixed-stem implant.

Data extraction {#sec1.3}
---------------

We collected information from each study including the year of publication, country of publication, study design, follow-up period, patient demographic characteristics, indications, and specific device. We also extracted outcome data to compare revision rates (secondary surgery for implant revision or removal), specific complication rates (arthritis, capitellar erosion, instability, and osteolysis), and functional scores (reported with either the Mayo Elbow Performance Score \[MEPS\] or Disabilities of the Arm, Shoulder and Hand \[DASH\] score).

Data analysis {#sec1.4}
-------------

We analyzed the outcome data using Open Meta-analyst software, pooling results across studies for each fixed-stem device using the DerSimonian-Laird random-effects method.[@bib38] Dichotomous data (revision and complications) were reported as the proportion of patients experiencing the event, and continuous data (function) were reported as mean scores on the MEPS or DASH questionnaire, with the associated 95% confidence intervals (CIs) for each estimate. For the MEPS, a higher score is indicative of a more favorable outcome, whereas for the DASH questionnaire, a lower score is more favorable. We also analyzed outcomes by injury type (ie, fracture only, heterogeneous population, Essex-Lopresti, or terrible triad) to investigate if certain patient populations demonstrated an increased risk of experiencing an event. If so, we conducted sensitivity analyses removing such outliers to limit the influence of confounding factors when interpreting the results and comparing effect estimates between the different implants. We also performed a subgroup analysis, grouping devices as either bipolar or monopolar implants.

Results {#sec2}
=======

Search results {#sec2.1}
--------------

We screened a total of 117 titles and abstracts ([Fig. 1](#fig1){ref-type="fig"}). Of these, 39 were included for full-text review, and a total of 9 studies were deemed eligible.[@bib13]^,^[@bib14]^,^[@bib20]^,^[@bib21]^,^[@bib27]^,^[@bib29]^,^[@bib31]^,^[@bib34]^,^[@bib35] In addition, 22 studies from the publication by Agyeman et al[@bib1] were eligible,[@bib2]^,^[@bib3]^,^[@bib5]^,^[@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12]^,^[@bib15]^,^[@bib16]^,^[@bib18]^,^[@bib22], [@bib23], [@bib24], [@bib25], [@bib26]^,^[@bib28]^,^[@bib30]^,^[@bib32]^,^[@bib33]^,^[@bib37] giving a total of 31 studies for the final analysis.Figure 1Flow diagram of included studies. *RHA*, radial head arthroplasty.

Description of included studies {#sec2.2}
-------------------------------

The included studies were published from 2001 to 2018 and were conducted across 15 different countries ([Table I](#tbl1){ref-type="table"}). The study sample sizes for each RHA device ranged from 6 to 63 patients, with an average length of follow-up ranging from 10.5 to 110.4 months (9.2 years). The average age of the patients ranged from 36 to 62 years, and the proportion of male patients ranged from 12.5% to 83.3%. In terms of the indications for surgery, the majority of studies included patients with radial head fractures only (23 studies), whereas the remaining studies included a heterogeneous population (5 studies), patients with a terrible-triad injury (2 studies), or patients with an Essex-Lopresti injury (1 study). Among the 31 included studies, the authors of 24 studies declared no financial conflicts or competing interests, 4 studies were published by authors who received benefits or consulting fees from third parties, and such disclosures were not reported in the remaining 3 studies.Table IIncluded studiesAuthor, yearCountryDesignPatients, nAverage follow-up, moAge, yrMale/female, nIndicationDevice (company)Gramlich et al,[@bib13] 2019GermanyRetrospective3532.44822/13Fractures onlyMoPyC (Tornier)3153.34719/12Fractures onlyrHead (SBi/Stryker)Hari Krishnan, and Gupta,[@bib14] 2019IndiaProspective30243621/9Fractures onlyNR (Phoenix Surgical)Laflamme et al,[@bib20] 2017CanadaRetrospective364852.828/29Fractures onlyExploR (Zimmer-Biomet)Laumonerie et al,[@bib21] 2017FranceRetrospective36110.4NRNRFractures onlyGuepar (SBi/Stryker)2436.7NRNRFractures onlyEvolutive (Aston Medical)1062.8NRNRFractures onlyrHead RECON (SBi/Stryker)753.2NRNRFractures onlyrHead (SBi/Stryker)Nestorson et al,[@bib27] 2017SwedenRetrospective875.159.1NRFracture onlyrHead (SBi/Stryker)105650.2NRFracture onlyAnatomic Radial Head (Acumed)Ricon et al,[@bib29] 2018SpainRetrospective1879.84813/5Fractures onlyMoPyC (Tornier)Rodriguez-Quintana et al,[@bib31] 2017Puerto RicoProspective142454.716/8Terrible-triad injuriesAnatomic Radial Head (Acumed)Sullivan et al,[@bib34] 2017United StatesRetrospective1910.5NRNRFracture onlyRadial Head Prosthesis (Synthes)6319.1NRNRFracture onlyExploR (Zimmer-Biomet)Tarallo et al,[@bib35] 2017ItalyRetrospective31305221/10Fractures onlyAnatomic Radial Head (Acumed)Allavena et al,[@bib2] 2014FranceRetrospective22504415/7Terrible-triad injuriesGuepar (SBi/Stryker)Berschback et al,[@bib3] 2013United StatesRetrospective1333468/5Essex-Lopresti injuriesAnatomic Radial Head (Acumed)Brinkman et al,[@bib5] 2005HollandRetrospective1124438/3Fractures onlyJudet (Tornier)Burkhart et al,[@bib7] 2010GermanyRetrospective1710644.114/3Heterogeneous populationJudet (Tornier)Celli et al,[@bib8] 2010ItalyRetrospective1641.746.111/5Fractures onlyJudet (Tornier)Chapman et al,[@bib9] 2006United StatesRetrospective1637509/7Heterogeneous populationSolar (Stryker)Dotzis et al,[@bib10] 2006FranceRetrospective126344.810/4Fractures onlyJudet (Tornier)El Sallakh,[@bib11] 2013EgyptRetrospective1242395/7Fractures onlyAnatomic Radial Head (Acumed)Gauci et al,[@bib12] 2016FranceRetrospective52465230/35Heterogeneous populationMoPyC (Tornier)Heijink et al,[@bib15] 2016The NetherlandsRetrospective2550557/18Fractures onlyRHS (Tornier)Katthagen et al,[@bib16] 2013GermanyRetrospective2925608/23Heterogeneous populationCorin (Corin Group)Kodde et al,[@bib18] 2016The NetherlandsRetrospective3048489/21Fractures onlyJudet (Tornier)Levy et al,[@bib22] 2016United StatesRetrospective1526629/6Fractures onlyAnatomic Radial Head (Acumed)Lim and Chan,[@bib23] 2008SingaporeRetrospective629.7532/4Fractures onlyVitallium (Howmedica)Lopiz et al,[@bib24] 2016SpainRetrospective1442546/8Fractures onlyMoPyC (Tornier)Moro et al,[@bib25] 2001CanadaRetrospective24 (25 elbows)395411/13Fractures onlyRichards (Smith & Nephew)Mou et al,[@bib26] 2015ChinaRetrospective1260.8416/6Fractures onlyAnatomic Radial Head (Acumed)Popovic et al,[@bib28] 2007BelgiumRetrospective511015132/19Fractures onlyJudet (Tornier)Ricon et al,[@bib30] 2012SpainRetrospective28325411/17Fractures onlyMoPyC (Tornier)Rotini et al,[@bib32] 2012ItalyRetrospective30 (31 elbows)244419/11Heterogeneous populationrHead (SBi/Stryker)Sarris et al,[@bib33] 2012GreeceRetrospective32275420/12Fractures onlyMoPyC (Tornier)Viveen et al,[@bib37] 2017The NetherlandsProspective1675492/14Fractures only (all revised cases)Judet (Tornier)[^1]

In terms of the specific fixed-stem implants, the studies evaluated devices from Acumed (Anatomical Radial Head \[versions not reported; Hillsboro, OR, USA\]), Aston Medical (Evolutive; Surrey, UK), Corin Group (Corin; Cirencester, UK), Howmedica (Vitallium; IN, USA), Phoenix Surgical (Cape Town, South Africa), SBi/Stryker (Guepar, rHead, rHead RECON, and Solar; Kalamazoo, MI, USA), Smith & Nephew (Richards; London, UK), Synthes (Radial Head Prosthesis; Warsaw, IN, USA), Tornier (Judet, MoPyC, and RHS; Edina, MN, USA), and Zimmer-Biomet (ExploR; Warsaw, IN, USA).

Revision rates {#sec2.3}
--------------

[Figure 2](#fig2){ref-type="fig"} displays the revision rates by indication. Studies on patients with terrible-triad injuries demonstrated a remarkably higher event rate than studies on the other patient populations and were removed from the analysis of revision rates by specific RHA device ([Fig. 3](#fig3){ref-type="fig"}). Relative to the overall revision rate for all fixed-stem devices (11.7%; 95% CI, 8.5%-14.9%), pooled rates were lower, based on the point estimates, for 7 of the 15 different devices, ranging between 4.4% and 10.5%: Anatomical Radial Head (Acumed), ExploR (Zimmer-Biomet), Judet (Tornier), Phoenix Surgical device, Vitallium (Howmedica), Radial Head System (Tornier), and Radial Head Prosthesis (Synthes). The remaining devices demonstrated revision rates ranging between 13.8% and 60%.Figure 2Revision rates (percentages) by indication. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.Figure 3Revision rates (percentages) by device. Studies on patients with terrible-triad injuries were removed. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

Complications {#sec2.4}
-------------

Patients with Essex-Lopresti injuries demonstrated remarkably higher rates of arthritis and were not included in the analysis of arthritis rates by specific RHA device ([Fig. 4](#fig4){ref-type="fig"}). Relative to the overall rate of development of arthritis for all fixed-stem devices (34.6%; 95% CI, 18%-51.2%), pooled rates were lower for 5 of the 9 different devices included in the analysis, ranging from 4.5% to 28.2%: Guepar (SBi/Stryker), Anatomic Radial Head (Acumed), Corin (Corin Group), Richards (Smith & Nephew), and rHead (SBi/Stryker). The remaining devices demonstrated arthritis rates ranging between 44% and 61.6%.Figure 4Arthritis rates (percentages) by device. Studies on patients with Essex-Lopresti injuries were removed. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

Patients with Essex-Lopresti injuries also showed a markedly increased risk of capitellar erosion and were removed from the analysis by RHA device ([Fig. 5](#fig5){ref-type="fig"}). Relative to the overall rate of capitellar erosion for all fixed-stem devices (20.1%; 95% CI, 12.4%-27.8%), pooled rates were lower for 5 of the 10 different devices eligible for the analysis, ranging from 1.9% to 18%: Richards (Smith & Nephew), Anatomic Radial Head (Acumed), Judet (Tornier), Radial Head System (Tornier), and rHead (SBi/Stryker). The remaining devices demonstrated capitellar erosion rates ranging between 20.8% and 60%.Figure 5Capitellar erosion rates (percentages) by device. Studies on patients with Essex-Lopresti injuries were removed. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

Patients with terrible-triad injuries showed a substantially higher rate of instability and were removed from the analysis by RHA device ([Fig. 6](#fig6){ref-type="fig"}). Relative to the overall rate of instability for all fixed-stem devices (5.7%; 95% CI, 3.1%-8.2%), pooled rates were lower for 4 of the 11 different devices included in the analysis, ranging from 1.7% to 4.4%: Corin (Corin Group), Anatomic Radial Head (Acumed), Solar (Stryker), and Judet (Tornier). The remaining devices demonstrated instability rates ranging between 6.7% and 19.9%.Figure 6Instability rates (percentages) by device. Studies on patients with terrible-triad injuries were removed. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

The rate of osteolysis was markedly greater in patients with an Essex-Lopresti injury, and such studies were removed from the analysis by RHA device ([Fig. 7](#fig7){ref-type="fig"}). Relative to the overall rate of osteolysis for all fixed-stem implants (40.1%; 95% CI, 27%-53.2%), pooled rates were lower for 6 of the 13 different devices eligible for the analysis, ranging from 1.7% to 39.9%: Corin (Corin Group), Anatomic Radial Head (Acumed), MoPyC (Tornier), Radial Head System (Tornier), Guepar (SBi/Stryker), and rHead (SBi/Stryker). The remaining devices demonstrated osteolysis rates ranging between 43.8% and 94.7%.Figure 7Osteolysis rates (percentages) by device. Studies on patients with Essex-Lopresti injuries were removed. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

Function {#sec2.5}
--------

[Figure 8](#fig8){ref-type="fig"} shows the analysis of function via the MEPS by RHA device. Relative to the overall MEPS for all fixed-stem implants (88.6 points; 95% CI, 86.6-90.5 points), pooled scores were greater for 4 of the 12 different devices eligible for the analysis, ranging from 89.6 to 96.2 points: ExploR (Zimmer-Biomet), Anatomic Radial Head (Acumed), MoPyC (Tornier), and Radial Head System (Tornier). The remaining devices demonstrated MEPS values ranging from 80 to 88 points.Figure 8Mean functional scores by device: Mayo Elbow Performance Score. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

[Figure 9](#fig9){ref-type="fig"} shows the analysis of function on the DASH questionnaire by RHA device. Relative to the overall DASH score for all fixed-stem implants (15.2 points; 95% CI, 13.1-17.4 points), pooled scores were more favorable for 5 of the 11 different devices eligible for the analysis, ranging from 8.8 to 13.9 points: ExploR (Zimmer-Biomet), Judet (Tornier), Anatomic Radial Head (Acumed), Vitallium (Howmedica), and Evolutive (Aston Medical). The remaining devices demonstrated DASH scores ranging from 16.1 to 27.5 points.Figure 9Mean functional scores by device: Disabilities of the Arm, Shoulder and Hand score. *LCI*, lower limit of confidence interval; *UCI*, upper limit of confidence interval.

Subgroup analysis {#sec2.6}
-----------------

Of the 15 devices identified in this review, 9 were monopolar (Anatomic Radial Head, Corin, ExploR, MoPyC, Radial Head Prosthesis, rHead, Richards, Solar, and Vitallium) and 6 were bipolar (Evolutive, Guepar, Judet, Phoenix Surgical, rHead RECON, and RHS). The results of these analyses are summarized in [Table II](#tbl2){ref-type="table"}. Overall, monopolar devices demonstrated more favorable results for the majority of outcomes, except for DASH scores, in terms of the pooled point estimates; however, the analyses may be confounded by wide CIs and a high degree of heterogeneity.Table IISubgroup analysis: monopolar vs. bipolar implantsOutcomePooled estimate across monopolar implantsPooled estimate across bipolar implantsRevision No. of studies2213 Estimate (95% CI), %10.0 (6.7-13.4)14.5 (7.8-21.2) *P* value for effect estimate\<.001\<.001 *I*^2^ for heterogeneity, %44.3378.92 *P* value for heterogeneity.014\<.001Arthritis No. of studies109 Estimate (95% CI), %28.3 (13.0-43.5)40.8 (12.6-69.0) *P* value for effect estimate\<.001.005 *I*^2^ for heterogeneity, %89.897.66 *P* value for heterogeneity\<.001\<.001Capitellar erosion No. of studies911 Estimate (95% CI), %18.7 (6.8-30.5)20.7 (12.5-28.9) *P* value for effect estimate.002\<.001 *I*^2^ for heterogeneity, %94.6167.57 *P* value for heterogeneity\<.001\<.001Instability No. of studies109 Estimate (95% CI), %5.6 (1.5-9.6)7.0 (3.4-10.7) *P* value for effect estimate.007\<.001 *I*^2^ for heterogeneity, %46.890 *P* value for heterogeneity.05.879Osteolysis No. of studies159 Estimate (95% CI), %36.1 (19.1-53.0)46.8 (24.0-69.5) *P* value for effect estimate\<.001\<.001 *I*^2^ for heterogeneity, %96.1195.33 *P* value for heterogeneity\<.001\<.001MEPS No. of studies1710 Estimate (95% CI), points89.48 (87.05-91.92)87.03 (84.24-89.81) *P* value for effect estimate\<.001\<.001 *I*^2^ for heterogeneity, %73.6450.98 *P* value for heterogeneity\<.001.031DASH score No. of studies127 Estimate (95% CI), points16.17 (12.76-19.59)14.57 (11.71-17.42) *P* value for effect estimate\<.001\<.001 *I*^2^ for heterogeneity, %24.635.93 *P* value for heterogeneity.202.154[^2]

Discussion {#sec3}
==========

Main findings {#sec3.1}
-------------

This systematic review and meta-analysis provided evidence highlighting that all fixed-stem RHA implants should not be considered equivalent to each other. Differences were seen between different devices (15 in total) across numerous outcomes, which included rates of revision, arthritis, capitellar erosion, instability, and osteolysis, as well as functional scores via either the MEPS or DASH questionnaire. When all evaluated outcomes were considered, the Anatomic Radial Head (Acumed) and ExploR (Zimmer-Biomet) devices generally performed well across most outcomes whereas rHead RECON (SBi/Stryker), Guepar (SBi/Stryker), Solar (SBi/Stryker), and MoPyC (Tornier) devices tended to show less favorable results; however, such conclusions are dependent on which of these outcomes are considered most important.

Agyeman et al[@bib1] reported overall revision rates of 7.9% for fixed-stem implants and 3.1% for unfixed stems. We calculated a revision rate of 11.7% for fixed-stem implants, as the additional studies included since the publication by Agyeman et al generally reported revision rates higher than 7.9%[@bib13]^,^[@bib14]^,^[@bib20]^,^[@bib21]^,^[@bib27]^,^[@bib29]^,^[@bib31]^,^[@bib34]; however, when we performed subgroup analysis by the specific RHA devices, revision rates were as low as 4.4% and as high as 60%, demonstrating how problematic it can be to group different devices together based on one similar characteristic. In addition, we noted that outcomes may be influenced by the type of patient receiving an RHA. Specifically, we saw evidence to suggest that patients with Essex-Lopresti or terrible-triad injuries may be at a greater risk of development of certain complications. This finding indicates that we should also evaluate these devices within the context of the patient population. Of note, there is currently no gold standard as to what are clinically important thresholds for revision and complication rates, and what is considered acceptable may vary from surgeon to surgeon. In addition, many of the reported complications may be based purely on radiographic findings within a given study, and it is unclear how many patients experiencing these complications may actually be symptomatic. In terms of the reasons for revision reported in the included literature, the data suggested that the most common reason for revision was to treat elbow joint stiffness and limited range of motion (making up approximately 31% of these revisions), followed by implant loosening, subluxation, and pain unrelated to implant loosening. This finding is consistent with the most commonly reported complications identified in the report by Agyeman et al.[@bib1] There may also be inconsistency in the criteria used to define some of the reported complications. For example, most of the studies providing data on the incidence of arthritis stated that they followed the Broberg-Morrey classification to measure the severity of ulnohumeral osteoarthritis[@bib6]; however, there were still a number of included studies that did not specify their method of measuring arthritis. Standardized definitions and reporting of outcomes would ensure comparability between studies and greater confidence in the pooled estimates.

In a previously published network meta-analysis of randomized controlled trials (RCTs) on displaced radial head fractures, we found that RHA resulted in better function and reduced postoperative complications compared with open reduction--internal fixation.[@bib36] Regarding the limited amount of evidence (only 4 RCTs), none of the included RCTs directly compared 2 different fixed-stem implants or compared fixed vs. unfixed stems. Such comparisons are currently limited to either prospective or retrospective cohort studies. In terms of fixed vs. unfixed stems, 1 prospective and 2 retrospective cohort studies found similar pain and functional outcomes with both implant fixation techniques; however, it was reported that fixed-stem implants led to greater osteolysis. It is unclear whether the higher rate of radial neck osteolysis is clinically meaningful and actually compromises pain or functional outcomes.[@bib3]^,^[@bib20]^,^[@bib31] Regarding studies directly comparing fixed-stem devices with each other, they also found differences in outcomes between different devices,[@bib13]^,^[@bib21]^,^[@bib27]^,^[@bib34] providing some further support that not all fixed-stem RHA implants are the same.

Limitations {#sec3.2}
-----------

A limitation of this study was the lack of randomized trial evidence. The analysis predominantly comprised data from observational studies (either case series or cohort studies), with variable follow-up lengths and small sample sizes. Higher-quality evidence, with direct comparisons, consistent outcome reporting, and comparable patient populations, would provide greater confidence in estimating the comparative effects between the different devices. In addition, certain devices may have been represented by a small number of studies. For example, the analysis of revision rates included 7 studies that evaluated the Judet (Tornier) device but only 1 study that evaluated the rHead RECON (SBi/Stryker). This may put into question the precision in the estimate for devices similar to the latter (ie, with limited data), and additional evidence on the device may change the observed outcome. Finally, definitions and criteria for an outcome to be considered a "study event" are subjective and may be inconsistent across studies, which could affect the reported estimates. Future researchers in this area should collaborate to standardize, as much as possible, the process of assessing these outcomes.

Conclusion {#sec4}
==========

This systematic review and meta-analysis provided evidence that fixed-stem RHA implants should not be considered equivalent to each other. Differences were seen in revision rates, postoperative complications, and functional scores. This study highlighted that these devices should be evaluated within the context of the patient population under examination, as patients with Essex-Lopresti or terrible-triad injuries may demonstrate worse outcomes relative to patients with isolated fractures only. Additional high-quality evidence is needed to further support these conclusions.

Disclaimer {#sec5}
==========
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[^1]: *NR*, not reported.

[^2]: *CI*, confidence interval; *MEPS*, Mayo Elbow Performance Score; *DASH*, Disabilities of the Arm, Shoulder and Hand.
